NCT06396819

Collagen-povidone for Diabetic Seniors' Tenosynovitis

Topical Collagen-povidone Injection as an Alternative Treatment for Stenosing Tenosynovitis in Older Adults With Type 2 Diabetes Mellitus

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Instituto Mexicano del Seguro Social · Other Government
• Sex: All
• Age: 60 Years
• Healthy volunteers: Accepted

Summary

Diabetes affects 415 million adults globally, leading to hand issues. Povidone collagen shows promise in managing tenosynovitis. A clinical trial was conduced to compared its efficacy in adults over 60. It is shown that the intervention reduces pain, improves functionality, and grip strength with no complications. Collagen povidone holds potential for treating diabetic hand issues.

Detailed description

A randomized clinical trial from January 2022 to January 2023 compared povidone collagen intervention with a placebo in adults aged 60 and above suffering from stenosing tenosynovitis. Participants were randomized into Case (collagen-povidone) and Control (physiological solution) groups. The study evaluated parameters like tenosynovitis, diabetes, pain, functionality, and grip strength.

Conditions

• Diabetes Complications

Interventions

Type	Name	Description
DRUG	collagen-povidone solution	Application of collagen-povidone solution at a dose of 0.2 cc, compared with the application of physiological solution in the control group

Timeline

• Start date: 2023-01-01
• Primary completion: 2024-01-01
• Completion: 2024-04-01
• First posted: 2024-05-02
• Last updated: 2024-05-02

Locations

1 site across 1 country: Mexico